Cancer Australia is pleased to announce the release of an Australian first clinical practice guideline, Recommendations for the management of early breast cancer in women with an identified BRCA1 or BRCA2 gene mutation or at high risk of a gene mutation.
The guideline provides health professionals with information to assist them in making management recommendations to improve outcomes for women.
- View the new Recommendations for the management of early breast cancer in women with an identified BRCA1 or BRCA2 gene mutation or at high risk of a gene mutation clinical practice guidelines here.
